University of California, San Francisco (UCSF)
About University of California, San Francisco (UCSF)
Check out the link below for more information on biotechnolgy-related research at UCSF.
598 articles with University of California, San Francisco (UCSF)
-
Frontier Medicines will support the continued development of the company’s chemoproteomics drug discovery program, including lead asset, an inhibitor of KRASG12C.
-
The device is at the core of the BRAVO trial, which evaluates signals to control complex devices for motor and speech in adults who have been severely affected by neurological disorders.
-
Drug companies have been suggesting that booster shots will be needed. However, it is up to the CDC's recommendation if booster shots are necessary.
-
Cambia Health Foundation Invests $1.5M in UCSF Division of Palliative Medicine to Improve Serious Illness Care through Innovation, Leadership and Collaboration
8/25/2020
New Foundation grant to fund innovative projects, national convenings and education programs that will enhance the skills of all health care providers and improve the experience of patients
-
They are approximately 25% of the size of human antibodies and from other animals, and they appear to be the most potent anti-coronavirus compound that has been tested in the laboratory so far.
-
A research team may have discovered a means to prevent breast cancer from spreading to other parts of the body through the blocking of a single enzyme.
-
Weill Neurohub Will Promote Cross-Institutional Collaboration in Brain Trauma and Neurodegenerati...
11/13/2019
The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift. -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Researchers at the University of California at San Francisco have discovered that a scorpion toxin can actually be harnessed to target the wasabi receptor, which is described as a “chemical-sensing protein” found in nerve cells.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...
-
Recently, we interviewed Bill Lindstaedt, who is the Assistant Vice Chancellor of Career Advancement, International and Postdoctoral Services at the University of California San Francisco. If you’ve ever wanted more information from an expert on careers in the life sciences, reviewing his career ...
-
AFM, a polio-like condition, has infected more than 500 children since 2014. Scientists may have discovered the root of the disease.
-
Here are some of the top research stories that happened around the industry this week.
-
Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers
5/1/2019
Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor
-
Researchers with the University of California San Francisco (UCSF) developed a “neural decoder” that translates brain activity to synthesize audible speech. They published their research in the journal Nature.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
April 11 is World Parkinson’s Day, designed to raise awareness of Parkinson’s disease. Parkinson’s is a progressive disease of the nervous system that affects movement.
-
Since Biogen and Tokyo-based Eisai recently reported a massive failure in Alzheimer’s research for their drug aducanumab, scientists and industry watchers are scanning the tea leaves looking for other potential approaches to treating the disease. One that is of interest is a hormone called Klotho.
-
When it comes to biotech and pharma innovation few places stand out like the Biotech Bay. The area is home to a plethora of innovative companies that are shaping the future of medical treatment for a variety of diseases and conditions on a daily basis.